Wells Fargo’s Moderna MRNA Stock Holding History

Wells Fargo’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.54M	Buy	+50,000	New	+$2.33M	﹤0.01%	3086
2023 Q2	–	Sell	-50,100	Closed	-$7.69M	–	7650
2023 Q1	$7.69M	Buy	50,100 +50,000	+50,000%	+$8.25M	﹤0.01%	1784
2022 Q4	$18K	Buy	+100	New	+$16.4K	﹤0.01%	5309
2022 Q3	–	Sell	-10,000	Closed	-$1.43M	–	7104
2022 Q2	$1.43M	Buy	10,000 +9,900	+9,900%	+$1.42M	﹤0.01%	3056
2022 Q1	$17K	Sell	100 -1,200	-92%	-$202K	﹤0.01%	6079
2021 Q4	$330K	Buy	+1,300	New	+$380K	﹤0.01%	4985
2021 Q3	–	Sell	-50,000	Closed	-$11.7M	–	7314
2021 Q2	$11.7M	Buy	+50,000	New	+$8.94M	﹤0.01%	2104
2021 Q1	–	Sell	-23,900	Closed	-$1.2M	–	7195
2020 Q4	$1.2M	Buy	+23,900	New	+$2.42M	﹤0.01%	3892

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's MRNA Position: Q1 2026 in Review

Wells Fargo increased its Moderna (MRNA) stake by 15% in Q1 2026, buying an estimated $884K and bringing the position to 143,765 shares worth $7.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Wells Fargo first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $220M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Wells Fargo held 143,765 shares of Moderna worth $7.3M as of Q1 2026.
Wells Fargo bought 18,958 Moderna shares in Q1 2026, an estimated $884K.
Moderna made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2276 holding.
Wells Fargo first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
Wells Fargo's Moderna position peaked at $220M in Q3 2021.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.